Tampa, FL– Robert Gillies, Ph.D., came to Moffitt Cancer Center to assemble an imaging program that provides Total Cancer Care by matching cancer patients to the best treatment. The Academy of Molecular Imaging is honoring Gillies as a Distinguished Basic Scientist recipient, as his achievements in research have significantly contributed to advancing the field of molecular imaging.
Gillies’ career successes have led to new understandings of the development and progression of cancer, as well as new cancer treatment options. Gillies spent years focusing on melanoma, pancreatic and breast cancers. He is expanding his expertise and research to lung cancer in hopes of being able to provide a more accurate diagnosis for each patient by analyzing features from tumor images.
“It’s our goal that imaging data can be used to identify which therapies a patient would be most likely to respond to,” Gillies said.
AMI will present Gillies with a $7,500 cash award at its annual conference in Montreal, Canada Sept. 23-26. Gillies will share his work with the attendees and will be published in AMI’s journal, Molecular Imaging and Biology.
Gillies believes the next frontier in the field will involve the conversion of image data to quantifiable numbers that can then be used in comparison with a patient’s profile. He expects this will provide a deeper level of understanding and a more vigorous approach to discovering an accurate prognosis.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.